Last Updated: September 24, 2026

Details for Patent: 11,097,063


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,097,063 protect, and when does it expire?

Patent 11,097,063 protects OZEMPIC and is included in one NDA.

This patent has fifteen patent family members in thirteen countries.

Summary for Patent: 11,097,063
Title:Syringe device with a dose limiting mechanism and an additional safety mechanism
Abstract:A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose.
Inventor(s):Jacob Eiland, Christian Peter Enggaard, Claus Schmidt Moeller, Tom Hede Markussen
Assignee: Novo Nordisk AS
Application Number:US16/250,620
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 11,097,063
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 11,097,063

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novo OZEMPIC semaglutide SOLUTION;SUBCUTANEOUS 209637-001 Dec 5, 2017 DISCN Yes No 11,097,063 ⤷  Start Trial Y Y ⤷  Start Trial
Novo OZEMPIC semaglutide SOLUTION;SUBCUTANEOUS 209637-004 Oct 6, 2022 RX Yes Yes 11,097,063 ⤷  Start Trial Y Y ⤷  Start Trial
Novo OZEMPIC semaglutide SOLUTION;SUBCUTANEOUS 209637-002 Apr 9, 2019 RX Yes Yes 11,097,063 ⤷  Start Trial Y Y ⤷  Start Trial
Novo OZEMPIC semaglutide SOLUTION;SUBCUTANEOUS 209637-003 Mar 28, 2022 RX Yes Yes 11,097,063 ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,097,063

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05016286Jul 27, 2005

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.